Bill Text: NY S08097 | 2023-2024 | General Assembly | Amended

---

Bill Title: Directs the commissioner of health to establish a blood clot and pulmonary embolism policy workgroup.

Spectrum: Bipartisan Bill

Status: (Engrossed) 2024-06-07 - referred to health [S08097 Detail]

Download: New_York-2023-S08097-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         8097--A
            Cal. No. 1494

                    IN SENATE

                                     January 8, 2024
                                       ___________

        Introduced  by  Sens. PERSAUD, MURRAY -- read twice and ordered printed,
          and when printed to be committed to the Committee on Health -- commit-
          tee discharged and said bill committed to the Committee  on  Rules  --
          ordered  to  a third reading, amended and ordered reprinted, retaining
          its place in the order of third reading

        AN ACT to amend the public health law, in  relation  to  establishing  a
          blood  clot and pulmonary embolism policy workgroup; and providing for
          the repeal of such provisions upon expiration thereof

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Section 206 of the public health law is amended by adding a
     2  new subdivision 32 to read as follows:
     3    32.  (a)  The  commissioner shall establish a blood clot and pulmonary
     4  embolism policy workgroup.  The workgroup shall be  composed  of  health
     5  care  providers,  patients  who  have  experienced  blood  clots, family
     6  members of patients who have died from blood clots, advocates, and other
     7  interested parties and associations. The governor, the temporary  presi-
     8  dent  of  the  senate and the speaker of the assembly shall each appoint
     9  two members to the workgroup.  The commissioner shall appoint the  chair
    10  of the workgroup.
    11    (b)  Members  of the workgroup shall receive no compensation for their
    12  services, but may be paid their actual and necessary  expenses  incurred
    13  in serving the workgroup.
    14    (c) It shall be the duty of the workgroup to study and issue recommen-
    15  dations  pertaining  to  the  incidence and treatment of blood clots and
    16  pulmonary embolisms within the state. The workgroup shall:
    17    (i) Identify the aggregate number of people who experience blood clots
    18  and pulmonary embolisms each year in this state.
    19    (ii) Identify how data is collected regarding blood  clots,  pulmonary
    20  embolisms, and adverse health outcomes associated with these conditions.
    21    (iii)  Identify  how  blood  clots  and pulmonary embolisms impact the
    22  lives of people in this state.
    23    (iv) Identify the standards  of  care  for  blood  clot  surveillance,
    24  detection, and treatment.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13187-02-4
        S. 8097--A                          2

     1    (v)  Identify emerging treatments, therapies, and research relating to
     2  blood clots.
     3    (vi)  Develop a risk surveillance system to help health care providers
     4  identify patients who may be at a higher risk of forming blood clots and
     5  pulmonary embolisms.
     6    (vii) Develop policy recommendations to help improve patient awareness
     7  of blood clot risks.
     8    (viii) Develop policy recommendations to help improve surveillance and
     9  detection of patients who may be at a higher risk of forming blood clots
    10  in licensed health care facilities, including hospitals, nursing  homes,
    11  assisted  living facilities, residential treatment facilities, and ambu-
    12  latory surgical centers.
    13    (ix) Develop policy recommendations relating to guidelines  used  that
    14  affect the standard of care for patients at risk of forming blood clots.
    15    (x)  Develop policy recommendations relating to providing patients and
    16  their families with written notice of increased risks of  forming  blood
    17  clots.
    18    (d)  The  chair  is  authorized  to  create subcommittees to help with
    19  research, scheduling speakers on  important  subjects,  and  drafting  a
    20  workgroup report and policy recommendations.
    21    (e)  No  later than one year after the effective date of this subdivi-
    22  sion, the workgroup shall submit their recommendations in the form    of
    23  a written report to the commissioner, the speaker of the  assembly,  the
    24  temporary  president of  the senate, the minority leader of the assembly
    25  and the minority leader of the senate.
    26    (f) Upon receipt of the  workgroup's  report, the  commissioner  shall
    27  publish such recommendations on the department's website.
    28    § 2. This act shall take effect on the ninetieth day  after  it  shall
    29  have  become a law and shall expire and be deemed repealed two years and
    30  ninety days after it shall have become a law.